News
Events
Press Releases
Careers
Contact Us
Home
About Us
Overview
Management
Board of Directors
Scientific Advisory Board
Careers
Product
Overview
RIZAPORT
®
Tadalafil
Loxapine
Montelukast
More Products
R&D Services
Overview
VersaFilm
VetaFilm
Services
Manufacturing Services
Overview
Manufacturing & Packaging
Services
Partnering
Overview
Trade Shows
BD Contacts
Investors
Overview
Shareholder Reports
Corporate Governance
Press Releases
Stock Price
Presentations
Regulatory Filings
XBRL Files
Analyst Coverage
Videos
RSS Feeds
IR Contact
Home
About Us
Overview
Management
Board of Directors
Scientific Advisory Board
Careers
Product
Overview
RIZAPORT<sup>®</sup>
Tadalafil
Loxapine
Montelukast
More Products
R&D Services
Overview
VersaFilm
VetaFilm
Services
Manufacturing Services
Overview
Manufacturing & Packaging
Services
Partnering
Overview
Trade Shows
BD Contacts
Investors
Overview
Shareholder Reports
Corporate Governance
Press Releases
Stock Price
Presentations
Regulatory Filings
XBRL Files
Analyst Coverage
Videos
RSS Feeds
IR Contact
INTELGENX
Home
>
Investors
>
Press Releases
INTELGENX
Home
>
Investors
>
Press Releases
Normal
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
IntelGenx Achieves Positive Bioequivalence Results With Novel Anti-Migraine Film
November 17, 2009
IntelGenx Reports Results For the Third Quarter and Nine Months Ended September 30, 2009
November 10, 2009
IntelGenx Determines Exercise Price of Stock Options to IR Firm
October 6, 2009
IntelGenx Strengthens Investor Relations Activities
October 1, 2009
IntelGenx Technologies Corp. Completes Additional Private Placement
September 4, 2009
IntelGenx Technologies Corp. Announces Shareholder Call
August 31, 2009
IntelGenx Corp. Comments on CPI-300 Patent Infringement Complaint
August 21, 2009
IntelGenx Reports Results for the Second Quarter and Six Months Ended June 30, 2009
August 14, 2009
IntelGenx Technologies Corp. Files Preliminary Short Form Prospectus; IntelGenx Completes Additional Private Placement
July 29, 2009
IntelGenx Technologies Corp. Announces Closing of Private Placement
July 14, 2009
IntelGenx Corp. Announces FDA Acceptance for Filing of NDA for CPI-300 Antidepressant
June 23, 2009
IntelGenx Corp. and Circ Pharma to Commence Phase 1 Proof-of-Concept Study of CRES Pravastatin, a Novel Low Dose Formulation Containing Pravastatin for the Treatment of Hyperlipidemia
May 19, 2009
IntelGenx Reports Results for the First Quarter of 2009
May 13, 2009
Positive Bioequivalence Results for IntelGenx Developed Product
April 20, 2009
IntelGenx Announces Appointment of New Director
April 15, 2009
Cannasat and IntelGenx Announce Positive Phase 1(b) Results Improved buccal tablet outperforms oral dronabinol
April 14, 2009
IntelGenx Corp. and Cary Pharmaceuticals file NDA for CPI-300 antidepressant
April 7, 2009
IntelGenx Technologies Corp. Announces 2008 Annual Financial Results
March 25, 2009
Cannasat Therapeutics and IntelGenx Corp. Reach Key Milestone
January 28, 2009
IntelGenx Corp. and Circ Pharma Ltd announced today a partnership to develop and commercialise a novel drug for the treatment of hyperlipidemia.
January 19, 2009
Home
About Us
Overview
Management
Board of Directors
Scientific Advisory Board
Careers
Product
Overview
RIZAPORT
®
Tadalafil
Loxapine
Montelukast
More Products
R&D Services
Overview
VersaFilm
VetaFilm
Services
Manufacturing Services
Overview
Manufacturing & Packaging
Services
Partnering
Overview
Trade Shows
BD Contacts
Investors
Overview
Shareholder Reports
Corporate Governance
Press Releases
Stock Price
Presentations
Regulatory Filings
XBRL Files
Analyst Coverage
Videos
RSS Feeds
IR Contact
Shareholder Tools
Financial Reports
E-mail Alerts
RSS News Feeds
About us
Overview
Management
Board of Directors
Careers
Product
Overview
RIZAPORT
®
Tadalafil
Loxapine
Montelukast
More Products
R&D Services
Overview
VersaFilm
®
Services
Manufacturing Services
Overview
Film Manufacturing
Services
Partnering
Overview
Investors
Overview
Financial Reports
Corporate Governance
Press Releases
Stock Price
Presentations
Regulatory Filings
Analyst Coverage
IR Contact
More Links
Facebook
Twitter
Linkedin
Contact us
Careers
Email Signup
RSS Feeds
© Copyright 2019. IntelGenx Corp. All Rights Reserved.
Terms of Service
Privacy
Contact Us
Powered By Q4 Inc.
5.24.1.3